JP2020532745A - 子癇前症と関連したバイオマーカーを検出するための方法及び装置 - Google Patents

子癇前症と関連したバイオマーカーを検出するための方法及び装置 Download PDF

Info

Publication number
JP2020532745A
JP2020532745A JP2020513919A JP2020513919A JP2020532745A JP 2020532745 A JP2020532745 A JP 2020532745A JP 2020513919 A JP2020513919 A JP 2020513919A JP 2020513919 A JP2020513919 A JP 2020513919A JP 2020532745 A JP2020532745 A JP 2020532745A
Authority
JP
Japan
Prior art keywords
level
biomarker
group
biomarkers
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020513919A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020532745A5 (https=
Inventor
カルロス シモン
カルロス シモン
スーザン フィッシャー
スーザン フィッシャー
タマラ ガリード
タマラ ガリード
Original Assignee
アイジェノミクス エセ．エレ．
アイジェノミクス エセ．エレ．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アイジェノミクス エセ．エレ．, アイジェノミクス エセ．エレ． filed Critical アイジェノミクス エセ．エレ．
Publication of JP2020532745A publication Critical patent/JP2020532745A/ja
Publication of JP2020532745A5 publication Critical patent/JP2020532745A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2561/00—Nucleic acid detection characterised by assay method
    • C12Q2561/113—Real time assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60—Detection means characterised by use of a special device
    • C12Q2565/626—Detection means characterised by use of a special device being a flow cytometer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4745—Insulin-like growth factor binding protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5756—Prolactin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90203—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2020513919A 2017-09-05 2018-09-05 子癇前症と関連したバイオマーカーを検出するための方法及び装置 Pending JP2020532745A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762554471P 2017-09-05 2017-09-05
US62/554,471 2017-09-05
PCT/IB2018/001117 WO2019048927A2 (en) 2017-09-05 2018-09-05 METHODS AND DEVICES FOR DETECTION OF BIOMARKERS ASSOCIATED WITH PRECLAMPSIA

Publications (2)

Publication Number Publication Date
JP2020532745A true JP2020532745A (ja) 2020-11-12
JP2020532745A5 JP2020532745A5 (https=) 2021-10-14

Family

ID=64184119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020513919A Pending JP2020532745A (ja) 2017-09-05 2018-09-05 子癇前症と関連したバイオマーカーを検出するための方法及び装置

Country Status (8)

Country Link
US (1) US20200271660A1 (https=)
EP (1) EP3679380A2 (https=)
JP (1) JP2020532745A (https=)
CN (1) CN111630387A (https=)
BR (1) BR112020004390A2 (https=)
CA (1) CA3074808A1 (https=)
MA (1) MA50123A (https=)
WO (1) WO2019048927A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022255401A1 (ja) * 2021-06-03 2022-12-08 国立大学法人 東京大学 Ｅｒｋ－ｍａｐｋ経路の異常な活性化に伴い発現する疾患マーカー

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11401552B2 (en) 2015-08-06 2022-08-02 University Of Utah Research Foundation Methods of identifying male fertility status and embryo quality
WO2021030725A1 (en) * 2019-08-15 2021-02-18 Washington State University Methods and kits for infertility diagnostics
CN110794136A (zh) * 2019-11-26 2020-02-14 中国人民武装警察部队特色医学中心 长链脂肪酸辅酶a连接酶1在诊断或预测子痫前期中的应用
KR102302742B1 (ko) * 2019-12-31 2021-09-15 의료법인 성광의료재단 임신중독증 진단용 바이오마커 조성물 및 이의 용도
MX2022015727A (es) * 2020-06-10 2023-03-23 Univ Texas Metodo para determinar riesgo de parto prematuro.
WO2022090050A1 (en) * 2020-10-26 2022-05-05 Institut National De La Sante Et De La Recherche Medicale Combination of biomarkers of preterm delivery
CN112630436A (zh) * 2021-01-25 2021-04-09 安士(广州)医疗科技有限公司 一种定量检测tex101浓度的荧光试剂条的制备方法及其应用
WO2022171318A1 (en) * 2021-02-12 2022-08-18 Ipremom Pregnancy Healthcare Diagnostics, S.L. In vitro method for determining the risk of suffering from preeclampsia
CN113406326B (zh) * 2021-06-01 2022-08-26 大连医科大学 一种用于预测子痫前期的生物学标志物及其应用
WO2022256617A1 (en) 2021-06-03 2022-12-08 Inherent Biosciences, Inc. Dna methylation analysis to identify cell type
CN114350805A (zh) * 2022-01-14 2022-04-15 中国人民解放军陆军军医大学第一附属医院 Ablim1作为胶质瘤分子标志物的应用
CN114822682B (zh) * 2022-04-12 2023-07-21 苏州市立医院 与早发型重度子痫前期发生相关的基因组合及其应用
CN115044669B (zh) * 2022-06-27 2023-05-16 山东第一医科大学附属省立医院(山东省立医院) 一种血浆lncRNA检测试剂盒及其应用
CN115873943B (zh) * 2023-02-13 2024-03-29 山东大学 骨形态发生蛋白2在子痫前期诊断、预防和治疗中的应用
CN117192096B (zh) * 2023-09-18 2026-04-03 上海交通大学医学院附属仁济医院 靶向抑制羊膜adamts4的化合物在制备筛选早产防治的药物中的用途
KR20250079483A (ko) * 2023-11-27 2025-06-04 의료법인 성광의료재단 임신 중기 임신중독증 예측 및 진단을 위한 질환 특이적인 바이오마커 및 그의 용도
KR20250079482A (ko) * 2023-11-27 2025-06-04 의료법인 성광의료재단 임신 초기 임신중독증 예측 및 진단을 위한 질환 특이적인 바이오마커 및 그의 용도
CN118275677B (zh) * 2024-06-03 2024-08-09 山东大学 检测erap2的试剂在制备预测poi预后情况的产品中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007051069A2 (en) * 2005-10-27 2007-05-03 Yale University Urinary proteomic biomarker patterns in preeclampsia
US20070178605A1 (en) * 2006-02-02 2007-08-02 Yale University Pregnancy biomarker profiles, methods and compositions related thereto
WO2010033553A2 (en) * 2008-09-16 2010-03-25 University Of Florida Research Foundation Inc. Gene expression related to preeclampsia
JP2017513021A (ja) * 2014-03-21 2017-05-25 アイジェノミクス エセ．エレ． 子癇前症の早期検出

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2861989A4 (en) * 2012-06-15 2016-03-02 Univ Wayne State BIOMARK TEST FOR PREDICTING OR EARLY IDENTIFICATION OF PRE-LAMPSY AND / OR HELLP SYNDROME
US9907833B2 (en) * 2013-07-25 2018-03-06 University Of Florida Research Foundation, Incorporated Use of relaxin to treat placental syndromes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007051069A2 (en) * 2005-10-27 2007-05-03 Yale University Urinary proteomic biomarker patterns in preeclampsia
US20070178605A1 (en) * 2006-02-02 2007-08-02 Yale University Pregnancy biomarker profiles, methods and compositions related thereto
WO2010033553A2 (en) * 2008-09-16 2010-03-25 University Of Florida Research Foundation Inc. Gene expression related to preeclampsia
JP2017513021A (ja) * 2014-03-21 2017-05-25 アイジェノミクス エセ．エレ． 子癇前症の早期検出

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FUGEDI, G. ET AL.: "Increased placental expression of cannabinoid receptor 1 in preeclampsia: an observational study", BMC PREGNANCY AND CHILDBIRTH, vol. Vol.14, Aritcle number: 395, JPN6022037557, 2014, pages 1 - 8, ISSN: 0005027666 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022255401A1 (ja) * 2021-06-03 2022-12-08 国立大学法人 東京大学 Ｅｒｋ－ｍａｐｋ経路の異常な活性化に伴い発現する疾患マーカー

Also Published As

Publication number Publication date
WO2019048927A2 (en) 2019-03-14
MA50123A (fr) 2020-07-15
CN111630387A (zh) 2020-09-04
CA3074808A1 (en) 2019-03-14
US20200271660A1 (en) 2020-08-27
WO2019048927A3 (en) 2019-04-18
BR112020004390A2 (pt) 2020-09-08
EP3679380A2 (en) 2020-07-15

Similar Documents

Publication Publication Date Title
JP2020532745A (ja) 子癇前症と関連したバイオマーカーを検出するための方法及び装置
JP7453669B2 (ja) ヒト機能性角膜内皮細胞およびその応用
Tapia et al. Differences in the endometrial transcript profile during the receptive period between women who were refractory to implantation and those who achieved pregnancy
Yao et al. Targeting endometrial inflammation in intrauterine adhesion ameliorates endometrial fibrosis by priming MSCs to secrete C1INH
CN106456694B (zh) 与循环肿瘤细胞相关的方法和测定法
Lu et al. CXCR4, CXCR7, and CXCL12 are associated with trophoblastic cells apoptosis and linked to pathophysiology of severe preeclampsia
Zhou et al. Infertile human endometrial organoid apical protein secretions are dysregulated and impair trophoblast progenitor cell adhesion
CN106461681A (zh) 用于诊断血管疾病的生物标志物及其用途
KR20140108718A (ko) 가와사키 질환용 바이오마커
Yin et al. Effect of lncRNA‐ATB/miR‐651‐3p/Yin Yang 1 pathway on trophoblast‐endothelial cell interaction networks
Sabetian et al. Comparing seminal plasma biomarkers between normospermic and azoospermic men
CN109952511B (zh) 用于确定先兆子痫的风险的测定方法
CN106191283B (zh) 多发性骨髓瘤生物标志物的诊治产品
US12607622B2 (en) Method for diagnosing and monitoring inflammatory disease progression
CN105886660A (zh) Uhrf1作为子宫内膜癌诊治标志物的用途
CN106011260B (zh) 一种诊治子宫内膜癌的分子标志物
US20220268780A1 (en) Methods of predicting endometrial receptivity
US20240210407A1 (en) Compositions and methods for detecting and treating pathological fibroblast cells
CN106011291B (zh) 一种诊治下咽癌的分子标志物
CN106119399B (zh) Znf385c作为下咽癌诊治标志物的用途
JP6721571B2 (ja) １５種類の男性生殖関連タンパク質またはその組み合わせの使用
US20150232932A1 (en) Ankrd26 as a marker for diagnosis of thrombocytopenias
Barros Characterization of human endometrial glandular epithelium in vitro and in vivo.
CN106148531A (zh) 下咽癌生物标志物
CN117778558A (zh) Igfbp3基因在制备筛查宫腔粘连的相关产品的应用

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20200811

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200811

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210903

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210903

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220830

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220906

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230404